Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The influence of two megsin polymorphisms on the progression of IgA nephropathy

Dita Maixnerová, Miroslav Merta, Jana Reiterová, Jitka Štekrová, Romana Ryšavá, Ondřej Viklický, H. Obeidová, Vladimír Tesař

. 2008 ; 54 (2) : 40-45.

Jazyk angličtina Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07513495

Grantová podpora
NR8913 MZ0 CEP - Centrální evidence projektů

The clinical course of chronic renal diseases and their progression to ESRD is highly variable. The strongest predictors of poor outcome of IgAN involve hypertension, severe proteinuria and elevated serum creatinine level. Different candidate gene polymorphisms have been advocated as possible modulators of the progression of IgAN. Megsin belongs to the serpin superfamily and was mapped to chromosome 18q21.3. Megsin plays a role in the regulation of a wide variety of processes in mesangial cells, such as matrix metabolism, cell proliferation, and apoptosis. Overexpression of Megsin might lead to mesangial dysfunction, and impair degradation of the mesangial matrix and disposal of immune complexes. The expression of Megsin is upregulated in a variety of glomerular diseases with mesangial injury in humans and in animal models. We investigated a possible association of two C2093T, C2180T polymorphisms of the megsin gene with the progression of IgAN towards ESRD, as well as the haplotype reconstruction of megsin gene polymorphisms and clinical manifestation of IgAN. We examined a group of 197 pts with histologically proven IGAN (84 pts with normal renal function, 113 pts with progressive renal insufficiency); as a control group we used 61 genetically unrelated healthy subjects. DNA samples from collected blood were genotyped for two singlenucleotide polymorphisms of megsin C2093T, C2180T by means of PCR with defined primers, electrophoresis on 2% agarose gel, UV light visualization and direct sequencing. The megsin genotype distribution showed no differences among the groups of IgAN with normal renal function, progressive renal insufficiency and the control group. According to haplotype analysis, the TT haplotype (defined as T-2093, T-2180 alleles) was substantially more frequent in pts with IgAN and normal renal function (Table 1, P = 0.025; Table 3, P = 0.062). Pts in the progressive group showed significantly higher levels of 24-h UP (3.53 +/- 2.80 vs 2.06 +/- 2.06, P = 0.042; Table 10), diastolic blood pressure (92.89 +/- 15.66 vs 84.93 +/- 10.43, P = 0.047; Table 10) and almost significantly systolic blood pressure (150.79 +/- 32.88 vs 135.21 +/- 14.88, P = 0.058; Table 10). We confirmed the negative prognostic influence of hypertension and proteinuria on the progression of IgAN in Czech pts. We found out that the TT haplotype (defined as T-2093, T-2180 alleles) could play a protective role in the progression of IgAN. In our Czech population, we excluded the negative influence of the 2093C-2180T haplotype, which was proposed by Chinese studies.

Bibliografie atd.

Lit.: 32

000      
00000naa 2200000 a 4500
001      
bmc07513495
003      
CZ-PrNML
005      
20140807094456.0
008      
081205s2008 xr e eng||
009      
AR
035    __
$a (PubMed)18498720
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Maixnerová, Dita $7 xx0063141 $u Department of Nephrology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
245    14
$a The influence of two megsin polymorphisms on the progression of IgA nephropathy / $c Dita Maixnerová, Miroslav Merta, Jana Reiterová, Jitka Štekrová, Romana Ryšavá, Ondřej Viklický, H. Obeidová, Vladimír Tesař
314    __
$a Charles University in Prague, First Faculty of Medicine, Department of Nephrology, Prague
504    __
$a Lit.: 32
520    9_
$a The clinical course of chronic renal diseases and their progression to ESRD is highly variable. The strongest predictors of poor outcome of IgAN involve hypertension, severe proteinuria and elevated serum creatinine level. Different candidate gene polymorphisms have been advocated as possible modulators of the progression of IgAN. Megsin belongs to the serpin superfamily and was mapped to chromosome 18q21.3. Megsin plays a role in the regulation of a wide variety of processes in mesangial cells, such as matrix metabolism, cell proliferation, and apoptosis. Overexpression of Megsin might lead to mesangial dysfunction, and impair degradation of the mesangial matrix and disposal of immune complexes. The expression of Megsin is upregulated in a variety of glomerular diseases with mesangial injury in humans and in animal models. We investigated a possible association of two C2093T, C2180T polymorphisms of the megsin gene with the progression of IgAN towards ESRD, as well as the haplotype reconstruction of megsin gene polymorphisms and clinical manifestation of IgAN. We examined a group of 197 pts with histologically proven IGAN (84 pts with normal renal function, 113 pts with progressive renal insufficiency); as a control group we used 61 genetically unrelated healthy subjects. DNA samples from collected blood were genotyped for two singlenucleotide polymorphisms of megsin C2093T, C2180T by means of PCR with defined primers, electrophoresis on 2% agarose gel, UV light visualization and direct sequencing. The megsin genotype distribution showed no differences among the groups of IgAN with normal renal function, progressive renal insufficiency and the control group. According to haplotype analysis, the TT haplotype (defined as T-2093, T-2180 alleles) was substantially more frequent in pts with IgAN and normal renal function (Table 1, P = 0.025; Table 3, P = 0.062). Pts in the progressive group showed significantly higher levels of 24-h UP (3.53 +/- 2.80 vs 2.06 +/- 2.06, P = 0.042; Table 10), diastolic blood pressure (92.89 +/- 15.66 vs 84.93 +/- 10.43, P = 0.047; Table 10) and almost significantly systolic blood pressure (150.79 +/- 32.88 vs 135.21 +/- 14.88, P = 0.058; Table 10). We confirmed the negative prognostic influence of hypertension and proteinuria on the progression of IgAN in Czech pts. We found out that the TT haplotype (defined as T-2093, T-2180 alleles) could play a protective role in the progression of IgAN. In our Czech population, we excluded the negative influence of the 2093C-2180T haplotype, which was proposed by Chinese studies.
650    _2
$a progrese nemoci $7 D018450
650    _2
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genotyp $7 D005838
650    _2
$a IgA nefropatie $x genetika $x patofyziologie $7 D005922
650    _2
$a haplotypy $7 D006239
650    _2
$a lidé $7 D006801
650    _2
$a chronické selhání ledvin $x genetika $7 D007676
650    _2
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a serpiny $x genetika $7 D015843
700    1_
$a Merta, Miroslav, $7 mzk2004248662 $u Department of Nephrology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic $d 1954-
700    1_
$a Reiterová, Jana $7 xx0018667 $u Department of Nephrology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Štekrová, Jitka $7 xx0061371 $u Department of Biology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Ryšavá, Romana, $d 1967- $7 xx0084071 $u Department of Nephrology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Viklický, Ondřej, $d 1966- $7 nlk20050170291 $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1#
$a Obeidová, H. $7 _BN002400 $u Department of Nephrology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Tesař, Vladimír, $d 1957- $7 jn20000402349 $u Department of Nephrology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00011004 $t Folia biologica $g Roč. 54, č. 2 (2008), s. 40-45 $x 0015-5500
856    41
$u https://fb.cuni.cz/Data/files/folia_biologica/volume_54_2008_2/fb2008a0008.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y 1 $z 0
990    __
$a 20081205075345 $b ABA008
991    __
$a 20140807094819 $b ABA008
999    __
$a ok $b bmc $g 629090 $s 481543
BAS    __
$a 3
BMC    __
$a 2008 $b 54 $c 2 $d 40-45 $i 0015-5500 $m Folia biologica (Praha) $x MED00011004
GRA    __
$a NR8913 $p MZ0
LZP    __
$a 2008-22/mkme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...